In Bloomberg Law, Health Care Partner Addresses Pay-for-Delay Drug Deals

In The News
March 13, 2019
Attorneys:
Thomas N. Bulleit
Capital Insights.

Health care partner Tom Bulleit (Washington, D.C.) is quoted in a Bloomberg Law article on March 11 that examines the impact of pay-for-delay prescription drug deals.

Mr. Bulleit suggests that the proposed CREATES Act, which would give generic drugmakers modest additional tools to more quickly bring a generic to market, may be more likely to succeed than other more forceful measures that have been discussed in Congress and in President Trump’s budget.

Attorneys

Thomas N. Bulleit
Thomas N. Bulleit
Retired Partner